Barclays’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$128K Sell
20,765
-452,802
-96% -$3.76M ﹤0.01% 3925
2025
Q4
$4.93M Buy
473,567
+164,804
+53% +$1.65M ﹤0.01% 2226
2025
Q3
$2.78M Buy
308,763
+234,253
+314% +$2.06M ﹤0.01% 2621
2025
Q2
$969K Buy
74,510
+19,444
+35% +$292K ﹤0.01% 3357
2025
Q1
$1.39M Sell
55,066
-9,741
-15% -$289K ﹤0.01% 2909
2024
Q4
$2.23M Buy
64,807
+6,021
+10% +$272K ﹤0.01% 2803
2024
Q3
$2.91M Buy
58,786
+46,783
+390% +$2.4M ﹤0.01% 2541
2024
Q2
$722K Sell
12,003
-13,543
-53% -$774K ﹤0.01% 2796
2024
Q1
$1.32M Sell
25,546
-18,063
-41% -$887K ﹤0.01% 2904
2023
Q4
$1.76M Buy
43,609
+34,862
+399% +$1.02M ﹤0.01% 3021
2023
Q3
$244K Sell
8,747
-319
-4% -$9.51K ﹤0.01% 3204
2023
Q2
$261K Sell
9,066
-2,956
-25% -$65.8K ﹤0.01% 3115
2023
Q1
$201K Buy
12,022
+6,493
+117% +$91.7K ﹤0.01% 3792
2022
Q4
$70.1K Buy
5,529
+4,656
+533% +$56.6K ﹤0.01% 4418
2022
Q3
$10K Sell
873
-160
-15% -$2.2K ﹤0.01% 4312
2022
Q2
$15K Sell
1,033
-1,819
-64% -$24K ﹤0.01% 4508
2022
Q1
$35K Buy
+2,852
New +$34.2K ﹤0.01% 4248

Other funds holding RXST

Barclays's RXST Position: Q1 2026 in Review

Barclays reduced its RxSight (RXST) stake by 96% in Q1 2026, selling an estimated $3.76M and leaving 20,765 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #3925.

Barclays first reported a position in RXST in Q1 2022 and has held it in 17 quarters since. The position peaked at $4.93M in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Barclays held 20,765 shares of RxSight worth $128K as of Q1 2026.
  • Barclays sold 452,802 RxSight shares in Q1 2026, an estimated $3.76M.
  • RxSight made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #3925 holding.
  • Barclays first reported a position in RxSight in Q1 2022 and has held it in 17 quarters since.
  • Barclays's RxSight position peaked at $4.93M in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.